CLINICAL TRIALS PROFILE FOR TOLSURA
✉ Email this page to a colleague
All Clinical Trials for TOLSURA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04809649 ↗ | SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole | Withdrawn | Mayne Pharma International Pty Ltd | Phase 2 | 2021-05-15 | The purpose of this study is to determine how safe, effective, and well tolerated a new investigational antifungal drug, SUBA-itraconazole, is for patients who have been previously treated with fluconazole and have had either an insufficient response to treatment with fluconazole or a negative reaction to fluconazole preventing their further treatment with it. |
NCT04809649 ↗ | SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole | Withdrawn | George R Thompson | Phase 2 | 2021-05-15 | The purpose of this study is to determine how safe, effective, and well tolerated a new investigational antifungal drug, SUBA-itraconazole, is for patients who have been previously treated with fluconazole and have had either an insufficient response to treatment with fluconazole or a negative reaction to fluconazole preventing their further treatment with it. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TOLSURA
Condition Name
Clinical Trial Locations for TOLSURA
Trials by Country
Clinical Trial Progress for TOLSURA
Clinical Trial Phase
Clinical Trial Sponsors for TOLSURA
Sponsor Name